Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections
出版年份 2021 全文链接
标题
Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections
作者
关键词
-
出版物
Transplantation Direct
Volume 7, Issue 10, Pages e762
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2021-09-09
DOI
10.1097/txd.0000000000001222
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysis
- (2021) Lindsay A. Sobotka et al. Annals of Hepatology
- Outcomes with Treatment with Glecaprevir/Pibrentasvir Following Heart Transplantation Utilizing Hepatitis C Viremic Donors
- (2020) Alex Reyentovich et al. CLINICAL TRANSPLANTATION
- Management and tolerability of glecaprevir‐pibrentasvir pharmacotherapy in hepatitis C viremic heart and lung transplant recipients
- (2020) Tyler C. Lewis et al. CLINICAL TRANSPLANTATION
- Increased early acute cellular rejection events in hepatitis C-positive heart transplantation
- (2020) Claudia G. Gidea et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Post‐transplant survey to assess patient experiences with donor‐derived HCV infection
- (2020) Katya Prakash et al. Transplant Infectious Disease
- Commercial insurance delays direct‐acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients
- (2020) Julia Torabi et al. Transplant Infectious Disease
- Pancreas Transplantation from Hepatitis C Viremic Donors to Uninfected Recipients
- (2020) Bonnie E. Lonze et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients
- (2020) Bashar Aqel et al. JOURNAL OF HEPATOLOGY
- Race, Education, and Gender Disparities in Transplantation of Kidneys From Hepatitis C Viremic Donors
- (2020) Tiffany Nguyen et al. TRANSPLANTATION
- Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients
- (2019) Ann E. Woolley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study
- (2019) Emily D Bethea et al. Lancet Gastroenterology & Hepatology
- Transplantation of kidneys from hepatitis C–infected donors to hepatitis C–negative recipients: Single center experience
- (2019) Miklos Z. Molnar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Fibrosing cholestatic hepatitis after kidney transplantation from HCV ‐viremic donors to HCV ‐negative recipients: A unique complication in the DAA era
- (2019) Nikhil Kapila et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Outcomes of heart transplantation from hepatitis C virus–positive donors
- (2019) Saima Aslam et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Lessons from the real world: HCV ‐infected donor kidney transplantation as standard practice
- (2019) Christine M. Durand et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Ultra‐short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients
- (2019) Gaurav Gupta et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Trends in utilization of deceased donor kidneys based on hepatitis C virus status and impact of public health service labeling on discard
- (2019) Venkatesh K. Ariyamuthu et al. Transplant Infectious Disease
- Hepatitis C‐positive donor liver transplantation for hepatitis C seronegative recipients
- (2019) Peng‐sheng Ting et al. Transplant Infectious Disease
- Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
- (2019) Marc G. Ghany et al. HEPATOLOGY
- Expanding Heart Transplant in the Era of Direct-Acting Antiviral Therapy for Hepatitis C
- (2019) Kelly H. Schlendorf et al. JAMA Cardiology
- Lung Transplantation from Hepatitis C Viremic Donors to Uninfected Recipients
- (2018) Ahmed Abdelbasit et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected Recipients
- (2018) Christine M. Durand et al. ANNALS OF INTERNAL MEDICINE
- The removal of DAA restrictions in Europe – one step closer to eliminating HCV as a major public health threat
- (2018) Alison D. Marshall et al. JOURNAL OF HEPATOLOGY
- Changes in utilization and discard of HCV-antibody positive deceased-donor kidneys in the era of direct-acting antiviral therapy
- (2018) Mary G. Bowring et al. TRANSPLANTATION
- Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study
- (2018) Charitha Gowda et al. Open Forum Infectious Diseases
- Twelve-Month Outcomes After Transplant of Hepatitis C–Infected Kidneys Into Uninfected Recipients
- (2018) Peter P. Reese et al. ANNALS OF INTERNAL MEDICINE
- Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors
- (2018) Allison J. Kwong et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients
- (2017) David S. Goldberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015
- (2016) Rose A. Rudd et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started